Ductal Carcinoma In Situ (DCIS) is the most common form of breast cancer wherein its progression interrupts the hormonal receptors and genetic variation of one’s DNA. DCIS can be caused by hereditary means, or through mutations. Fortunately, due to the many different modes of contraction, there is a plethora of treatments available in the forms of mastectomy, radiation, chemotherapeutic drugs, and PARP inhibitors, each with their own mechanism of action to combat the tumor and any metastatic effects the cancer may have on the body. This paper analyzes the cancer’s mechanism of action upon the body and the positive effects available treatments have to combat the disease.
Picciotto, M. (2022). Effective Treatments for Ductal Carcinoma In Situ. The Science Journal of the Lander College of Arts and Sciences, 15(2), 78-85. Retrieved from https://touroscholar.touro.edu/sjlcas/vol15/iss2/13